Cancer research has significantly advanced in understanding prevention and epidemiology, offering hope for reducing its global burden. Prevention focuses on mitigating risk factors like tobacco use, poor diet, and sedentary lifestyles. Public health initiatives, including vaccinations for HPV and hepatitis B, have proven effective in lowering incidences of cervical and liver cancers.
Epidemiology provides valuable insights by studying cancer patterns, causes, and distribution. It helps identify high-risk populations and environmental triggers, paving the way for targeted interventions. Advances in genetic profiling further enable the early detection of hereditary cancers. Combining these strategies enhances cancer prevention, fostering healthier communities and improving global health outcomes.
Title :
Pietro Salvatori, Private Practice, Italy
Title :
Jianhua Luo, University of Pittsburgh, United States
Title :
Marika Crohns, Sanofi, Germany
Title : RNA binding proteins in the pathogenesis of pediatric cancer
Atif A Ahmed, University of Washington-Seattle Children’s Hospital, United States
Title : A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy
Rajvir Dahiya, University of California San Francisco, United States
Title : The future of pharmacogenetic polymorphism, pharmacogenomics and pharmamicrobiome in cancer treatment
Bene Ekine-Afolabi, University of East London, United Kingdom